The objective of this study was to investigate the inhibitory effect of cucurbitacin I (CuI) and Ecballium elaterium L. (fruit juice and chloroform extract) on breast cancer cells (MCF-7 and MDA-MB-231). The CuI content of E. elaterium fruit juice and chloroform extract was quantified using high performance liquid chromatography. The cytotoxic effects of the fruit juice, chloroform extract and CuI were determined by MTT, wound healing and colony formation assays; all had an anti-proliferative activity on the breast cancer cells. Clarifying the mechanisms of cucurbitacins will enable the identification of new molecular targets for breast cancer therapy.
Ecballium elaterium (L.) A. Rich, family Cucurbitaceae, known as the 'squirting cucumber', is found abundantly in the Mediterranean region. The fresh juice of the fruit has been used as a folk medicine for the treatment of rhinosinusitis in Anatolia [1] . The juice is also used for the treatment of sinusitis and jaundice by nasal aspiration, but some toxic symptoms are observed, such as Quincke's disease (uvular angioedema), mucous membrane irritation, slobbering, dysphagia, and vomiting [2, 3] . E. elaterium has been used for its anti-inflammatory, antipyretic, anticancer, analgesic, antimicrobial, antitumor, immunomodulatory, and hepatoprotective activities, and also for the treatment of fever, liver disorders, jaundice, constipation, hypertension, dropsy, rheumatic diseases, agglutination of erythrocytes, and modification of the heart rate [3] [4] [5] [6] [7] .
The main pharmacological and biological activities have been linked with cucurbitacins, which have been isolated from E. elaterium [6] . The juice has a strong bitter taste and due to this, cucurbitacin acts as a stimulant purgative agent by increasing gastric secretion. Among the major constituents are cucurbitacin I, D, E, B, L, and R [6, 8] . Cucurbitacins act as a JAK/STAT inhibitor, a MAPK modulator and cytoskeleton disruptor. These features have enabled them to become popular agents in cancer treatment and cancer prevention studies. In our previous study we investigated the anti-proliferative effect of cucurbitacin I (CuI) on human colorectal cancer cell lines SW620 and LS174T [9] .
In the present study, we have studied the anti-proliferative components of E. elaterium juice, in particular CuI, and evaluated its action on breast cancer cell lines. The cytotoxic effect of CuI, E. elaterium fruit juice and chloroform extract on MCF-7 and MDA-MB-231 breast cancer cells were analyzed by MTT assay.
MCF-7 cells were treated with 400 nM of cucurbitacin I, which inhibited cell proliferation in a time-dependent manner, with inhibition rates of 16.7% at 24 hours, 53.0% at 48 hours, and 68.8% at 72 hours. The IC 50 value was 330.1nM at 48 hours and 35.1nM at 72 hours. Similarly, MCF-7 cells were treated with 10 mg/mL of E. elaterium fruit juice, which inhibited cell proliferation in a timedependent manner, with inhibition rates of 52.5% at 24 hours, 75.0% at 48 hours, and 85.2% at 72 hours. The IC 50 value was 5.2 mg/mL at 24 hours, 0.038 mg/mL at 48 hours, and 0.00088 mg/mL at 72 hours. MCF-7 cells were treated with 0.1 mg/mL of an E. elaterium chloroform extract, which inhibited cell proliferation in a time-dependent manner, with inhibition rates of 48.2% at 24 hours, 73.2% at 48 hours, and 87.5% at 72 hours. The IC 50 value was 0.0049 mg/mL at 48 hours, and 0.000025 mg/mL at 72 hours.
MDA-MB-231 cells were treated with 400 nM of cucurbitacin I, which inhibited cell proliferation in a time-dependent manner, with inhibition rates of 42.3% at 24 hours, 57.9% at 48 hours, and 82.5% at 72 hours. The IC 50 value was 183.5 nM at 48 hours and 17.7nM at 72 hours. MDA-MB-231 cells were treated with 10 mg/mL of E. elaterium fruit juice, which inhibited cell proliferation in a timedependent manner with inhibition rates of 22.9% at 24 hours, 26.4% at 48 hours, and 52.5% at 72 hours. The IC 50 value was 4.21 mg/mL at 72 hours. When treated with 0.1 mg/mL of E. elaterium chloroform extract cell proliferation was also inhibited in a timedependent manner, with inhibition rates of 34.6% at 24 hours, 44.9% at 48 hours, and 64.9% at 72 hours. The IC 50 value was 0.0025 mg/mL at 72 hours.
The wound healing assay was followed over 36 h for the low concentrations used in the cytotoxicity assay. Both cell lines displayed different migratory profiles during wound healing. In the case of the MCF-7 cells, the initial wound distance in the control group was 226 µm, and decreased to 62 µm after 36 hours (72.6% reduction), while the wound distances in cells treated with 400 nM of cucurbitacin increased from 222 µm to 267 µm after 36 hours (16.8% increase). This effect is likely to be the result of a combination of induced cell death and a reduced rate of cell proliferation. The initial wound distance in the control group was 271 µm, which decreased to 86 µm after 36 hours (68.3% reduction). The wound distance in cells treated with 10 mg/mL of E. elaterium fruit juice increased from 213 µm to 257 µm after 36 hours (17.1% increase), while the initial wound distance in the control group was 209 µm, which decreased to 56 µm after 36 hours (73.2% reduction In the case of the MDA-MB-231 cells, the initial wound distance in the control group was 210 µm, and decreased to 46 µm after 36 hours (78.1% reduction), while the wound distance in cells treated with 400 nM of cucurbitacin increased from 209 µm to 240 µm after 36 hours (12.9% increase). The initial wound distance in the control group was 207 µm, but decreased to 72 µm after 36 hours (65.2% reduction), while the wound distance in cells treated with 10 mg/mL of E. elaterium fruit juice increased from 263 µm to 336 µm after 36 hours (21.7% increase). The initial wound distance in the control group was 228 µm, but decreased to 19 µm after 36 hours (91.7% reduction), while the wound distance in cells treated with 0.1 mg/mL of an E. elaterium chloroform extract increased from 226 µm to 277 µm after 36 hours (18.4% increase).
The results obtained in the clonogenic assay support the MTT and wound healing results. We have determined that treatment with CuI, E. elaterium fruit juice and the chloroform extract destroys the colony forming ability of the cells in both cancer cell lines.
To explore the effects of cucurbitacin I and E. elaterium on colony formation, we treated MCF-7 cells with cucurbitacin I, fruit juice of E. elaterium and the chloroform extract of E. elaterium. The average colony number was 113 in the control group, 102 in cells treated with 0.4 nM of cucurbitacin I, 85 in cells treated with 4 nM of cucurbitacin I, and 11 in cells treated with 40 nM of cucurbitacin I. No colonies were observed in cells treated with 400 nM of cucurbitacin I. The average colony number was 123 in the control group, whereas no colonies were observed in cells treated with E. elaterium fruit juice. We also treated MCF-7 cells with a chloroform extract of E. elaterium, after which an average colony number of 186 was recorded in the control group, whereas no colonies were observed in cells treated with the chloroform extract.
We also carried out a clonogenic assay on MDA-MB-231 cells. The average colony number was 126 in the control group, 105 in cells treated with 0.4 nM of cucurbitacin I, and 8 in cells treated with 4 nM of cucurbitacin I. No colonies were observed in the cells treated with 40 nM and 400 nM of cucurbitacin I. The average colony number was 153 in the control group, whereas no colonies were observed in cells treated with fruit juice of E. elaterium. The average colony number was 186 in the control group, whereas no colonies were observed in cells treated with chloroform extract of E. elaterium.
Treatment of MCF-7 cells with cucurbitacin I brings about a change in cell morphology and inhibits cell proliferation. At 400 nM concentration, cucurbitacin I treatment induced apoptosis, and resulted in cell death; at 0.01 mg/mL concentration, E. elaterium fruit juice impaired the mobility of MCF-7 cells, while higher concentrations (1 mg/mL and 10 mg/mL) induced apoptosis and cell death. At 0.0001 and 0.001 mg/mL concentrations, treatment with chloroform extract of E. elaterium reduced the mobility of MCF-7 cells and inhibited cell proliferation. At 0.1 mg/mL, the treatment resulted in substantial cell death. We observed that the cucurbitacin I treatment caused changes in the morphology of MDA-MB-231 cells, and inhibited their proliferation. The most striking effects were observed at 40 nM and 400 nM concentrations, both of which led to substantial cell death. At 0.01 mg/mL and 1 mg/mL concentrations, E. elaterium fruit juice impaired the mobility of MDA-MB-231 cells, and induced apoptosis; however, treatment with 10 mg/mL concentrations gave rise to substantial cell death. At 0.0001 mg/mL and 0.001 mg/mL concentrations, treatment with chloroform extract of E. elaterium inhibited the proliferation of MDA-MB-231 cells, while treatment with 0.1 mg/mL caused substantial cell death.
For centuries, fruits and roots of E. elaterium have been used for medicinal purposes. The ethyl acetate fraction of the ethanolic extract of E. elaterium inhibited cell proliferation of hepatocarcinoma cell line HepG2 [10] . In another study, Bohlooli et al. showed that freeze-dried extract of E. elaterium fruit exerts cytotoxic effects on gastric adenocarcinoma cell line AGS and esophageal squamous cell carcinoma cell line KYSE30 by inducing apoptosis [11] . Seed oil of E. elaterium, isolated by n-hexane Soxhlet extraction at 80°C, had antiproliferative effects on colon cancer (HT29) and adenosarcoma (HT1080) cells [12] .
Studies of E. elaterium have shown that the plant is a powerful antitumor agent, which has been attributed to the presence of cucurbitacins in the plant [13] [14] [15] [16] . Cucurbitacins inhibit JAK-STAT and MAPK pathways, which are essential for the proliferation and survival of cancer cells [17] . Cucurbitacin I exerts antiproliferative and antitumor activities, both in vitro and in vivo, through inhibition of the JAK/STAT-3 pathway [18] . An in vivo model of breast cancer showed that cucurbitacin I inhibited breast cancer growth by reducing STAT3 expression in tumor-associated B-cells [19] ; cucurbitacin I inhibited differentiation of mouse 3T3-L1 and C3H10T1/2 adipocytes [20] ; combination treatments with cucurbitacin I and bortezomib reduced STAT3 expression, increased heat-shock protein (HSP90) expression, and restored dendritic cell function [21] . Cucurbitacin I suppressed STAT3 expression and improved the response of non-small cell lung cancer (NSCLC) to chemoradiotherapy [22] ; cucurbitacin I induced apoptosis and autophagy in glioblastoma cells [23] . Cucurbitacin I treatment sensitized BJAB, I-83 and NALM-6 cells to apoptosis [24] ; cucurbitacin I treatment increased the sensitivity of ATCCD133+cells to radiation and chemotherapeutic agents [25] .
The anticancer and anti-inflammatory effects of cucurbitacins B, D, E, and I have been explored extensively in previous studies. Cucurbitacin I inhibits cell proliferation in colon cancer (HCT-116), breast cancer (MCF-7), lung cancer (NCI-H460) and astrocytoma (SF-268) cell lines [26] . In a study of mouse melanoma cells (B16-F1), it was shown that cucurbitacin I caused modifications to the chemical structures of the cofilin and gelsolin proteins, and delayed the depolymerization of actin filaments [27] . Cucurbitacin I also inhibits vascular endothelial growth factor 2 (VEGF2) and fibroblast growth factor 1 (FGF1) -two proteins with key roles in endothelial cell functions and angiogenesis, and in human umbilical vein endothelial cells (HUVEC) [28] . Kim et al. showed that cucurbitacin I inhibited the cell proliferation of SW480 cells, and reduced the protein expression of multiple cell cycle-related proteins, including cyclin B1, cyclin A, CDK1 and CDC25C. Moreover, the authors also showed that cucurbitacin I inhibited the growth of CT-26 colon carcinoma cells in BALB-c mice [29] .
In this study, we isolated fruit juice and chloroform extract from mature fruits of E. elaterium. The cucurbitacin I content of these samples was analyzed by HPLC, and an MTT assay was used to explore the antiproliferative effects of the fruit juice, chloroform extract and cucurbitacin I on the MCF-7 and MDA-MB-231 cell lines. A wound healing test was used to assess cell migration, and a clonogenic assay was used to assess colony formation ability. Both cell lines were examined under a microscope to evaluate the changes in cell morphology.
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Natural Product Communications Vol. 13 (11) 2018 1447 We also carried out an in vitro study towards the treatment of breast cancer, using cucurbitacin I, which has been reported to be an anticancer agent in multiple studies, as well as E. elaterium fruit juice and chloroform extract, which are considered to have antiproliferative effects. We treated MCF-7 and MDA-MB-231 breast cancer cell lines with different concentrations of these agents over different time periods and used an MTT assay to evaluate the inhibitory effects on cell proliferation. In addition, after treatment the cells were examined under a microscope to assess the changes in cell morphology.
The results of the MTT assay indicated that all three agents had antiproliferative effects on the cancer cells, and inhibited cell proliferation. E. elaterium fruit juice, chloroform extract, and cucurbitacin I exerted dose-and time-dependent inhibitory effects on both breast cancer cell lines, suggesting a potential utilization in the treatment of breast cancer. Recent studies support the antiproliferative effect of E. elaterium fruit juice, chloroform extract and cucurbitacin I [10] [11] [12] 26] , further supporting our observations. Angiogenesis consists of three major steps: activation of cells, proliferation and migration. Wound healing experiments on both cell lines showed that cells in the control group continued to migrate at 36 hours, while treatment with E. elaterium fruit juice, chloroform extract and cucurbitacin I resulted in a marked reduction in cell migration. These results suggest the potential antimetastatic effects of the three products on cancer cells.
The results of the colony formation experiments support those of the MTT assay. Above a certain dose, E. elaterium fruit juice, chloroform extract and cucurbitacin I all inhibited the colony formation ability of both cell lines. Moreover, the results of wound healing experiments suggest that all three agents may have antimetastatic effects on cancer cells. We evaluated the cellular morphology of both the MCF-7 and MDA-MB-231 cell lines. The cells in the control group maintained a normal cell proliferation, without any marked changes in morphology. The treated cells, on the other hand, had altered morphology, with the cells being smaller, and marked cell death was visible.
Overall, we believe that this pioneering study may lead the way for future studies into new treatment methods for breast cancer to contribute to the development of effective treatment protocols.
Experimental
General: RPMI medium 1640 and L-glutamine were purchased from Lonza (Basel, Switzerland), fetal bovine serum (FBS) from Biowest (Nuaille, France), penicillin/streptomycin from GIBCO/Invitrogen (Karlsruhe, Germany), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) powder from Serva (Heidelberg, Germany),and CuI standards from Merck (Darmstadt, Germany). All reagents and medium were prepared just before use.
Plant material: Ripe fruits of E. elaterium were collected from Adana city, Turkey. The voucher specimens were deposited in the Herbarium of İnönü University in Malatya, Turkey. (Herbarium Code: 7529). Fruits were squeezed manually, their juice collected in glass jars, filter-sterilized through 0.45 µm filters, and stored at -18°C.
Cell culture: Human breast cancer cell lines MCF-7 and MDA-MB-231 were kindly provided from the German Cancer Research Center (Heidelberg, Germany). The cells were cultured in RPMI-1640 medium supplemented with 10% (FBS) and L-glutamine (2 mM). The cell lines were maintained in an incubator with a humidified atmosphere (5% CO 2 in air at 37°C). Cells were passaged 2 or 3 times weekly using a solution of trypsin/ethylenediaminetetraacetic acid (EDTA).
MTT assay: Cell proliferation was assessed by using the MTT colorimetric assay as described by Eyol [30] , with some modifications. In brief, MTT solution (5 mg/mL in PBS) was added (10 μL/well). Plates were further incubated for 3 h, and, following discarding of the medium, the cells were lysed and formazan crystals were dissolved by the addition of 100 μL solvent (0.04 N HCl acid in 2-propanol) per well and then thoroughly mixed. Optical density was measured at a 570 nm using a microplate reader (Epoch, BioTek).
Wound healing (scratch) assay: MCF-7 and MDA-MB-231 cells were seeded in 24-well plates (30 x10 3 /mL) for 24 h, then each well was wounded by scratching with a 200 µL sterile plastic pipette tip, as described by Kaleagasıoglu [31] . The cells were then rinsed with culture medium to remove debris. Then, the cells were treated with indicated concentrations of CuI (0.4, 4, 40 and 400 nM), E. elaterium fruit juice (0.01, 0.1, 1 and 10 mg/mL) and chloroform extract (0.0001, 0.001, 0.01 and 0.1 mg/mL). At 0, 12, 24 and 36 h cells were photographed under an inverted microscope and the ImageJ 1.48 program was used for the measurements.
Colony formation assay:
The procedure described by Tekedereli was used, with some modifications [32] . The cells were seeded (500 cells/well) into 6-well plates. After 24 h, the cells were treated with the indicated concentrations of CuI, E. elaterium fruit juice and chloroform extract every 4 days, and 10 days and then the cells were washed with PBS and stained with crystal violet (0.05%).
Chromatographic conditions: For chromatographic analysis, a 1220LC HPLC system (Herts, U.K.) was used equipped with a Nucleosil 100-5 C18 250x4.6 mm column. Gradient elution was performed by varying the proportion of solvent A (acetonitrilewater 20:80, v/v) and solvent B (acetic acid-water, 1:99, v/v). Starting at 20% of solvent B, the proportion was programmed to reach 55% at 30 min. and total analysis time was 55 min. The flow rate was 1.0 mL/min. and detection at 229 nm by UV absorption. Each sample was run in duplicate for 3 independent experiments.
Statistical analysis: Data were analyzed using SPSS software version 22.0. Results of all experiments were expressed as mean values ± standard deviation (SD). Dunnett's test was used to compare two groups of unpaired values, whereas for comparisons between groups of more than two unpaired values, the KruskalWallis H test was used. p values <0.05 were considered to indicate statistically significant results.
